Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Swahn

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Human Reproduction (Oxford, England)|October 1, 1988
The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometriumM L Swahn, E Johannisson, V Daniore, et al.
Human Reproduction (Oxford, England)|January 1, 1994
Termination of early pregnancy with ZK 98,734: pharmacokinetic behaviour and clinical effectM L Swahn, L Kovács, S Z Cekan, et al.
International Journal of Cancer|October 16, 2010
Endometriosis as a prognostic factor for cancer survivalA Melin, C Lundholm, N Malki, et al.
Human Reproduction (Oxford, England)|May 1, 1990
The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometriumM L Swahn, M Bygdeman, S Cekan, et al.
Contraception|November 1, 1986
Plasma levels of antiprogestin RU 486 following oral administration to non-pregnant and early pregnant womenM L Swahn, G Wang, A R Aedo, et al.
Human Reproduction (Oxford, England)|January 1, 1997
Effect of low daily doses of mifepristone on ovarian function and endometrial developmentK G Danielsson, M L Swahn, P Westlund, et al.
Human Reproduction (Oxford, England)|February 1, 1996
Effect of low weekly doses of mifepristone on ovarian function and endometrial developmentK Gemzell-Danielsson, P Westlund, E Johannisson, et al.
Human Reproduction (Oxford, England)|January 1, 1989
Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancyM L Swahn, G Ugocsai, M Bygdeman, et al.
Diabetes Research and Clinical Practice|September 6, 2002
Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitusB Persson, M-L Swahn, R Hjertberg, et al.
Human Reproduction (Oxford, England)|November 5, 1999
Contraceptive efficacy of daily administration of 0.5 mg mifepristoneL Marions, S Viski, K G Danielsson, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Human Reproduction (Oxford, England)|October 1, 1988
The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometriumM L Swahn, E Johannisson, V Daniore, et al.
Human Reproduction (Oxford, England)|January 1, 1994
Termination of early pregnancy with ZK 98,734: pharmacokinetic behaviour and clinical effectM L Swahn, L Kovács, S Z Cekan, et al.
International Journal of Cancer|October 16, 2010
Endometriosis as a prognostic factor for cancer survivalA Melin, C Lundholm, N Malki, et al.
Human Reproduction (Oxford, England)|May 1, 1990
The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometriumM L Swahn, M Bygdeman, S Cekan, et al.
Contraception|November 1, 1986
Plasma levels of antiprogestin RU 486 following oral administration to non-pregnant and early pregnant womenM L Swahn, G Wang, A R Aedo, et al.
Human Reproduction (Oxford, England)|January 1, 1997
Effect of low daily doses of mifepristone on ovarian function and endometrial developmentK G Danielsson, M L Swahn, P Westlund, et al.
Human Reproduction (Oxford, England)|February 1, 1996
Effect of low weekly doses of mifepristone on ovarian function and endometrial developmentK Gemzell-Danielsson, P Westlund, E Johannisson, et al.
Human Reproduction (Oxford, England)|January 1, 1989
Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancyM L Swahn, G Ugocsai, M Bygdeman, et al.
Diabetes Research and Clinical Practice|September 6, 2002
Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitusB Persson, M-L Swahn, R Hjertberg, et al.
Human Reproduction (Oxford, England)|November 5, 1999
Contraceptive efficacy of daily administration of 0.5 mg mifepristoneL Marions, S Viski, K G Danielsson, et al.
Pageof 6